Innovations, technologies and methodologies in driving drug discovery developme across Asia
Dr Olivier Heudi | Head, Translational Sciences Novartis Institute for Biomedical Research
Olivier Heudi obtained his diploma of advanced studies in physiology and pharmacology at Pasteur Institute Paris (France) in 1995 and his Ph.D. in life Sciences at the University of Angers France in 1999. He previously gained experience in the analytical field at GSK Stevenage (UK) where he has implemented LC-ICPMS and LC-MS/MS for the quantification of peptide in biological fluids and at Nestlé Lausanne (CH) where he developed LC-MS/MS methods for the identification and quantification of vitamins and natural ingredients in food products and in raw materials. Then he joined Novartis Institute for Tropical Diseases (Singapore) where he was leading the bioanalytical laboratory. In December 2006, Olivier was appointed as laboratory head in the DMPK group where he is now working on LC-MS/MS method development and implementation for the quantification of monoclonal antibodies, oligonucleotides and small molecules in biological matrixes. Olivier is active as reviewer in several analytical papers and has great interest in new technologies with special attention on large molecules.
Share this
Appearances at this years' conference:
Conference Day 2: 21 March 2012
@ 14.20
High throughput quantitative analysis of new chemical entities in biological fluids: can we achieve a 10 second analysis time per sample?
High throughput quantitative analysis in biological fluids
Sample preparation protein precipitation and Solid phase extraction
Laser diode thermal desorption and APCI-MS
› Dr Olivier Heudi, Head, Translational Sciences, Novartis Institute for Biomedical Research